Studies on AhR found that it can be implicated in protection from cardiovascular disease, but depending on the ligand, it can also be implicated in atherosclerosis, so the results are controversial because studies showed the induction of PON1, but at the same time they can inhibit PON1, since they can be responsible for oxidative stress. Here, PON1 is linked to cardiovascular disorder.